SCYX · Scynexis Inc
Market Cap
$43.68M
Shares
9.95M
Volume · Oct 5
356.47K
Avg daily vol (3M)
272.2K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.03
Open$5.09
Day$4.83–5.20
52W close$3.57–8.88
Avg vol 30d382K
Short int460K · 4.6% float · 9.7d
Short vol26%
Last earningsNov 9, 2022
DataJan 2020–Oct 2026
Filing10-Q · Aug 10
Up next
filed Aug 10, 2026
call held Nov 9, 2022
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$19.21M
Trailing 12 months
Net income (TTM)
−$10.23M
Trailing 12 months
Revenue growth YoY
-82.8%
Year over year
Operating margin
-117.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+90.1%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
4.6%
Latest settlement · 9.7 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
+3%
above
RSI (14)
54
neutral
MACD trend
Positive
52-week position
27%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−38%
trailing
YTD return
−1%
this year
Relative strength
−50%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-13% holders QoQ · +9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.62% of float · ▲ +1.3% MoM · 9.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — mid 3-yr range
Squeeze score
66
elevated · 0–100
Fundamentals
Revenue growth
0%
Y/Y
Gross margin
1392%
expanding
EPS growth
+61%
Y/Y
Free cash flow
$-5.3M
Balance sheet
$70.1M
net cash
Quant / Vol
risk profile
Volatility
73%
annualized · 1-yr
Max drawdown
−60%
past year
ATR
8.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
+3%
Bullish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
27%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-13% holders QoQ · +9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.62% of float · ▲ +1.3% MoM · 9.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $4
Now $5 · 27%
Range high $9
vs 200-day avg -11%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SCYX
this stock
Scynexis Inc
|
$43.68M | — | +0.0% | — | 4.6% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$60.23B | +14.2% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$46.00B | -6.1% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$45.67B | +27.1% | +4.3% | 64.3 | 2.7% |
|
HLN
Haleon plc
|
$40.72B | -12.8% | — | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SCYX | +8.9% | -5.1% | -38.4% | +1.8% | -0.5% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | +7.7% | -5.7% | -49.9% | +0.2% | -14.1% |